Showing results (111-120 of 166) with videos related to
Sort By:
Pageof 17
Clinical & Experimental Metastasis|January 1, 1990
Combination chemotherapy with cisplatin and nifedipine: synergistic antitumor effects against a cisplatin-resistant subline of the B16 amelanotic melanomaJ M Onoda, K K Nelson, S M Pilarski, et al.The Prostate|May 15, 1998
Role of alphaII(b)beta3 integrin in prostate cancer metastasisM Trikha, E Raso, Y Cai, et al.Oncogene|October 5, 1995
Somatic mutations of the WAF1/CIP1 gene in primary prostate cancerX Gao, Y Q Chen, N Wu, et al.Radiation Research|December 1, 1994
Inhibition of radiation-enhanced expression of integrin and metastatic potential in B16 melanoma cells by a lipoxygenase inhibitorJ M Onoda, S S Kantak, M P Piechocki, et al.Cell Motility and the Cytoskeleton|January 1, 1993
PKC mediates 12(S)-HETE-induced cytoskeletal rearrangement in B16a melanoma cellsJ Timar, D Tang, R Bazaz, et al.Invasion & Metastasis|January 1, 1987
Inhibition of tumor cell induced platelet aggregation by prostacyclin and carbacyclin: an ultrastructural studyD G Menter, C Harkins, J Onoda, et al.FEBS Letters|February 13, 1989
Enhanced levels of cathepsin B mRNA in murine tumorsK Moin, J Rozhin, T B McKernan, et al.Cancer Research|November 1, 1996
Human prostate carcinoma cells express functional alphaIIb(beta)3 integrinM Trikha, J Timar, S K Lundy, et al.Cancer Research|December 15, 1987
Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variantsJ Rozhin, D Robinson, M A Stevens, et al.Clinical & Experimental Metastasis|January 1, 1987
Tumor cell-platelet interactions in vitro and their relationship to in vivo arrest of hematogenously circulating tumor cellsD G Menter, J S Hatfield, C Harkins, et al.Pageof 17